|A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer|
S Paik, S Shak, G Tang, C Kim, J Baker, M Cronin, FL Baehner, ...
New England Journal of Medicine 351 (27), 2817-2826, 2004
|Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor–positive breast cancer|
S Paik, G Tang, S Shak, C Kim, J Baker, W Kim, M Cronin, FL Baehner, ...
Journal of clinical oncology 24 (23), 3726-3734, 2006
|HER2 Status and Benefit from Adjuvant Trastuzumab in Breast Cancer|
S Paik, C Kim, N Wolmark
New England Journal of Medicine 358 (13), 1409-1411, 2008
|Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value|
PG Gavin, LH Colangelo, D Fumagalli, N Tanaka, MY Remillard, ...
Clinical cancer research 18 (23), 6531-6541, 2012
|Gene-expression-based prognostic assays for breast cancer|
C Kim, S Paik
Nature reviews Clinical oncology 7 (6), 340-347, 2010
|Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor–positive breast cancer|
C Kim, G Tang, KL Pogue-Geile, JP Costantino, FL Baehner, J Baker, ...
Journal of clinical oncology 29 (31), 4160, 2011
|Multi-gene RT-PCR assay for predicting recurrence in node negative breast cancer patients-NSABP studies B-20 and B-14|
S Paik, S Shak, G Tang, C Kim, J Baker, M Cronin, R Baehner, M Walker, ...
Breast Cancer Research and Treatment 82, S10-S11, 2003
|Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31|
KL Pogue-Geile, C Kim, JH Jeong, N Tanaka, H Bandos, PG Gavin, ...
Journal of the National Cancer Institute 105 (23), 1782-1788, 2013
|Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial|
L Pusztai, JH Jeong, Y Gong, JS Ross, C Kim, S Paik, R Rouzier, F Andre, ...
Journal of clinical oncology 27 (26), 4287, 2009
|Technology insight: Application of molecular techniques to formalin-fixed paraffin-embedded tissues from breast cancer|
S Paik, C Kim, Y Song, W Kim
Nature Clinical Practice Oncology 2 (5), 246-254, 2005
|Expression of the 21 genes in the Recurrence Score assay and tamoxifen clinical benefit in the NSABP study B-14 of node negative, estrogen receptor positive breast cancer|
S Paik, S Shak, G Tang, C Kim, J Baker, M Cronin, D Watson, J Bryant, ...
Journal of Clinical Oncology 23 (16_suppl), 510-510, 2005
|Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)|
EA Perez, MF Press, AC Dueck, RB Jenkins, C Kim, B Chen, I Villalobos, ...
Breast Cancer Research and Treatment 138, 99-108, 2013
|Benefit from adjuvant trastuzumab may not be confined to patients with IHC 3+ and/or FISH-positive tumors: Central testing results from NSABP B-31|
S Paik, C Kim, J Jeong, CE Geyer, EH Romond, O Mejia-Mejia, ...
Journal of Clinical Oncology 25 (18_suppl), 511-511, 2007
|Trastuzumab sensitivity of breast cancer with co-amplification of HER2 and cMYC suggests pro-apoptotic function of dysregulated cMYC in vivo.|
C Kim, J Bryant, Z Horne, CE Geyer, DL Wickerham, N Wolmark, S Paik
Breast cancer research and treatment 94, S6-S7, 2005
|Expression of the 21 genes in the Recurrence Score assay and prediction of clinical benefit from tamoxifen in NSABP study B-14 and chemotherapy in NSABP study B-20|
S Paik, S Shak, G Tang, C Kim, H Joo, J Baker, M Cronin, D Watson, ...
Breast Cancer Research and Treatment 88, S15-S15, 2004
|Methods of whole genome or microarray expression profiling using nucleic acids prepared from formalin fixed paraffin embedded tissue|
S Paik, K Pogue-Geile, C Kim
US Patent App. 11/796,752, 2007
|Akt phosphorylation at Ser473 predicts benefit of paclitaxel chemotherapy in node-positive breast cancer|
SX Yang, JP Costantino, C Kim, EP Mamounas, D Nguyen, JH Jeong, ...
Journal of Clinical Oncology 28 (18), 2974, 2010
|Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials|
DT Ross, C Kim, G Tang, OL Bohn, RA Beck, BZ Ring, RS Seitz, S Paik, ...
Clinical cancer research 14 (20), 6602-6609, 2008
|Biomarker discovery for colon cancer using a 761 gene RT-PCR assay|
KM Clark-Langone, JY Wu, C Sangli, A Chen, JL Snable, A Nguyen, ...
BMC genomics 8 (1), 1-18, 2007
|Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines|
J Kim, J Lee, SY Jang, C Kim, Y Choi, A Kim
Oncology reports 35 (5), 2553-2560, 2016